ClinicalTrials.govpublic full text
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis
moderate-to-severe atopic dermatitis, atopic dermatitis, nemolizumab, cd14152, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 873274
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.